Investing Profile

Hongbo Lu

InvestorVC

Managing Partner at Lilly Asia Ventures

Your Intro Paths to Hongbo Lu

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Hongbo is a member of

University of California, Berkeley, Haas School of Business Network

174 CONNECTIONS

University of Washington Network

98 CONNECTIONS

OrbiMed Network

32 CONNECTIONS

Piper Jaffray Network

30 CONNECTIONS

VIVO Capital Network

11 CONNECTIONS

Find Hongbo Lu on

Current Investing Position

Investment Range

$10.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Hongbo Lu is on these Sector & Stage Rankings

Hongbo Lu's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Ronovo Surgical	Series BAug 2023$27M Series AApr 2021	$27M
Rgenta Therapeutics	Series ANov 2022$52M SeedMay 2021$18M	$90M
Co-investors: Martin Heidecker (Hotmail), Fei Shen (Boehringer Ingelheim Venture Fund)
Zenas BioPharma	Series BNov 2022$120M	$320M
Co-investors: Jake Nunn (SR One Capital Management)
Visirna Therapeutics	SeedApr 2022$60M	$60M
Co-investors: Gaurav Aggarwal (Vivo Capital)
Avistone Pharmaceuticals	Series ADec 2021$200M	$200M
Ablaze Pharmaceuticals	Series ANov 2021$75M	$75M
Co-investors: Aaron Royston (venBio)
Avedro	Series FMay 2018$25M Series ENov 2015$32M	$180M
Co-investors: Jonathan Silverstein (OrbiMed), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest), Doug Cole (Flagship Ventures), David Berry (Flagship Ventures), Phil Ferneau (Borealis Ventures), Eric Sillman (Aperture Venture Partners)
Turning Point Therapeutics	Series CMay 2017$45M	$130M
Co-investors: Carl Gordon (OrbiMed Advisors), Simeon J. George (SR One), Chandra Leo (HBM Partners AG)